Skip to main content

Broccoli Extract Lowers Blood Sugar in Diabetics

Concentrated sulforaphane, a chemical found in broccoli, reduced blood glucose levels in type 2 diabetes patients by 10 percent in a small trial.

Written byDiana Kwon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

PIXABAY, CONGERDESIGNA powder containing a highly concentrated dose of sulforaphane, a chemical found in broccoli sprouts, was able to lower blood sugar levels in individuals with type 2 diabetes, according to a study published Wednesday (June 14) in Science Translational Medicine.

“We’re very excited about the effects we’ve seen and are eager to bring the extract to patients,” study coauthor Anders Rosengren of the University of Gothenburg in Sweden tells New Scientist. “We saw a reduction of glucose of about 10 percent, which is sufficient to reduce complications in the eyes, kidneys, and blood.”

Rosengren and colleagues conducted a 12-week placebo-controlled trial in which 97 people with type 2 diabetes took either a highly concentrated sulforaphane powder (with a dose 100 times that found naturally in broccoli) or a placebo. Most participants continued to take metformin, a drug commonly used to lower blood sugar levels in diabetics.

The team discovered that their compound was able to reduce participant’s fasting blood glucose by 10 percent compared with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays